- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Pioneer ACOs Show Quality of Care Improvements
First year results are in - all 32 participants in the Pioneer Accountable Care Organization (ACO) initiative showed success in improving quality. However, not as much success was made in cost savings.
The participants in the Obama administration's most aggressive experiment with accountable care had better success improving quality than lowering costs, according to first-year results revealed in a published report.
All 32 of the accountable care organizations in the program improved patient care and patient satisfaction against benchmarks, according to results shared with the Wall Street Journal in advance of their public release. Only 13 achieved enough savings that they qualified to share some of that money. Two ended up spending more on the assigned beneficiaries than traditional Medicare fee-for-service and will owe the government $4 million.
The challenge of assuming financial risk for achieving the targets has prompted several of the participants to consider leaving the program and potentially entering more flexible ACO contracts in the Medicare Shared Savings Program.
Read the full story here: http://bit.ly/18lgBFv
First year results are in - all 32 participants in the Pioneer Accountable Care Organization (ACO) initiative showed success in improving quality. However, not as much success was made in cost savings. Modern Healthcare reports:
What's at Stake as Oral Arguments Are Presented in the Braidwood Case? Q&A With Richard Hughes IV
April 21st 2025Richard Hughes IV, JD, MPH, spoke about the upcoming oral arguments to be presented to the Supreme Court regarding the Braidwood case, which would determine how preventive services are guaranteed insurance coverage.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
Comparing Breast Cancer Treatment Outcomes Between Fee-for-Service and Medicare Advantage
April 4th 2025This study examined postdiagnosis breast cancer treatment outcomes for Medicare Advantage vs fee-for-service (FFS) Medicare in Ohio and found no significant differences overall but disparities for Black patients with FFS Medicare.
Read More
